J Anim Sci Biotechnol. 2015 Sep 14;6(1):42. doi: 10.1186/s40104-015-0041-0. eCollection 2015.
No effect of exogenous melatonin on development of cryopreserved metaphase II oocytes in mouse.
Journal of animal science and biotechnology
Wei Li, Keren Cheng, Yue Zhang, Qinggang Meng, Shi'en Zhu, Guangbin Zhou
Affiliations
Affiliations
- Institute of Animal Genetics and Breeding, College of Animal Science and Technology, Sichuan Agricultural University (Chengdu Campus), Wenjiang, 611130 P.R. China ; Institute of Animal Genetics and Breeding, College of Animal Science and Technology, China Agricultural University, Beijing, 100193 P.R. China.
- Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah USA.
- Institute of Animal Genetics and Breeding, College of Animal Science and Technology, Sichuan Agricultural University (Chengdu Campus), Wenjiang, 611130 P.R. China.
- Nanjing Biomedical Research Institute of Nanjing University, Nanjing, 210089 P.R. China.
PMID: 26380081
PMCID: PMC4568589 DOI: 10.1186/s40104-015-0041-0
Abstract
BACKGROUND: This study was conducted to investigate effect of exogenous melatonin on the development of mouse mature oocytes after cryopreservation.
RESULTS: First, mouse metaphase II (MII) oocytes were vitrified in the open-pulled straws (OPS). After warming, they were cultured for 1 h in M2 medium containing melatonin at different concentrations (0, 10(-9), 10(-7), 10(-5), 10(-3) mol/L). Then the oocytes were used to detect reactive oxygen species (ROS) and glutathione (GSH) levels (fluorescence microscopy), and the developmental potential after parthenogenetic activation. The experimental results showed that the ROS level and cleavage rate in 10(-3) mol/L melatonin group was significantly lower than that in melatonin-free group (control). The GSH levels and blastocyst rates in all melatonin-treated groups were similar to that in control. Based on the above results, we detected the expression of gene Hsp90aa1, Hsf1, Hspa1b, Nrf2 and Bcl-x1 with qRT-PCR in oocytes treated with 10(-7), or 10(-3) mol/L melatonin and untreated control. After warming and culture for 1 h, the oocytes showed higher Hsp90aa1 expression in 10(-7) mol/L melatonin-treated group than in the control (P < 0.05); the Hsf1, Hsp90aa1 and Bcl-x1 expression were significantly decreased in 10(-3) mol/L melatonin-treated group when compared to the control. Based on the above results and previous research, we detected the development of vitrified-warmed oocytes treated with either 10(-7) or 0 mol/L melatonin by in vitro fertilization. No difference was observed between them.
CONCLUSIONS: Our results indicate that the supplementation of melatonin (10(-9) to 10(-3) mol/L) in culture medium and incubation for 1 h did not improve the subsequent developmental potential of vitrified-warmed mouse MII oocytes, even if there were alteration in gene expression.
Keywords: Gene expression; Melationin; Mouse oocyte; Parthenogenetic activation; vitrificantion
References
- J Pineal Res. 2013 Nov;55(4):325-56 - PubMed
- J Pineal Res. 2014 Apr;56(3):333-42 - PubMed
- Zygote. 2012 May;20(2):199-207 - PubMed
- PLoS One. 2011 Feb 15;6(2):e17109 - PubMed
- Mol Reprod Dev. 2008 Mar;75(3):538-46 - PubMed
- Reprod Biol Endocrinol. 2005 Jul 14;3:28 - PubMed
- Fertil Steril. 1985 Oct;44(4):493-8 - PubMed
- Vet Res Commun. 2002 Feb;26(2):151-8 - PubMed
- J Pineal Res. 2006 Mar;40(2):101-9 - PubMed
- Endocrinology. 2011 Jul;152(7):2806-15 - PubMed
- Methods. 2001 Dec;25(4):402-8 - PubMed
- Mol Reprod Dev. 1995 Jun;41(2):232-8 - PubMed
- Cryobiology. 2007 Oct;55(2):115-26 - PubMed
- Mol Reprod Dev. 2014 Jun;81(6):497-513 - PubMed
- Reprod Domest Anim. 2009 Feb;44(1):12-6 - PubMed
- J Pineal Res. 2009 Jan;46(1):22-8 - PubMed
- J Pineal Res. 2009 May;46(4):383-91 - PubMed
- News Physiol Sci. 2000 Oct;15:246-250 - PubMed
- Free Radic Biol Med. 2008 Apr 1;44(7):1295-304 - PubMed
- Nature. 2000 Oct 12;407(6805):693-4 - PubMed
- Theriogenology. 2013 Jul 15;80(2):161-8 - PubMed
- J Pineal Res. 2000 Jan;28(1):48-51 - PubMed
- Gene. 2012 Jul 15;503(1):1-11 - PubMed
- J Biomed Sci. 2000 Nov-Dec;7(6):444-58 - PubMed
- Theriogenology. 2006 Jan 7;65(1):236-44 - PubMed
- J Pineal Res. 2012 Sep;53(2):122-8 - PubMed
- Reprod Biol. 2005 Mar;5(1):5-17 - PubMed
- Fertil Steril. 2011 Dec;96(6):1357-61 - PubMed
- J Biol Chem. 2003 Nov 28;278(48):48021-9 - PubMed
- Biochim Biophys Acta. 2012 Mar;1823(3):656-67 - PubMed
- J Pineal Res. 2009 Nov;47(4):318-23 - PubMed
- J Biol Chem. 2009 Apr 3;284(14):9521-8 - PubMed
- J Pineal Res. 2013 Apr;54(3):245-57 - PubMed
- Trends Pharmacol Sci. 2015 Jan;36(1):6-14 - PubMed
- Fertil Steril. 2009 Jul;92(1):328-43 - PubMed
- Theriogenology. 2011 Sep 15;76(5):785-93 - PubMed
- Fertil Steril. 2010 Feb;93(3):959-66 - PubMed
- Mol Reprod Dev. 2009 Feb;76(2):122-31 - PubMed
- Theriogenology. 2012 Jan 1;77(1):21-7 - PubMed
- J Pineal Res. 2013 Oct;55(3):267-74 - PubMed
- Endocrine. 2005 Jul;27(2):119-30 - PubMed
- Mol Reprod Dev. 1998 Sep;51(1):53-8 - PubMed
- J Pineal Res. 2011 Aug;51(1):1-16 - PubMed
- Anim Reprod Sci. 2014 Mar;145(3-4):150-60 - PubMed
- J Genet Genomics. 2007 Mar;34(3):214-22 - PubMed
- J Reprod Fertil Suppl. 1971 Jun;14:7-21 - PubMed
- Free Radic Biol Med. 2007 Apr 15;42(8):1201-10 - PubMed
- J Pineal Res. 2007 Oct;43(3):283-8 - PubMed
- Cell Stress Chaperones. 2011 May;16(3):275-85 - PubMed
- Reprod Biol Endocrinol. 2012 Dec 03;10:103 - PubMed
- Biol Reprod. 2011 Nov;85(5):884-94 - PubMed
- J Pineal Res. 2005 Jan;38(1):1-9 - PubMed
- Reprod Biomed Online. 2013 Jan;26(1):22-9 - PubMed
Publication Types